MENINGIOMA

This study is testing whether an oral cancer drug called ribociclib can get into the brain and reach recurrent brain tumors. It involves 48 adults with recurrent high-grade glioma or meningioma who are scheduled for surgery. Patients take the drug for a short time before their op…

This study is testing two repurposed cancer drugs, brigatinib and neratinib, to see if they can slow or stop the growth of tumors in people with NF2-related schwannomatosis. It will enroll about 100 participants aged 12 and older who have specific, growing tumors. The trial uses …

This study aimed to learn about a drug called ONC201 for people with a type of brain tumor (meningioma) that had come back or stopped responding to other treatments. It planned to test the drug in two groups: people scheduled for surgery and people with no other treatment options…

This study is testing whether a targeted radiation therapy called Lutathera can control the growth of meningioma brain tumors in adults. It will involve 32 participants with progressive or high-risk tumors that have a specific marker showing they might respond to this treatment. …

This study is testing whether a more focused, higher-dose form of proton radiation can better control aggressive brain tumors called meningiomas. It involves 21 adults with specific types of these tumors that have been partially or fully removed by surgery. The main goal is to fi…

This study is collecting real-world information on how a specific surgical patch, called Neuro-Patch, performs when doctors use it to repair the protective lining around the brain or spinal cord. It involves 328 patients who had this patch placed during various neurosurgical proc…